Lorazepam (Ativan) for Anxiety in Personal Injury Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 7 min read

Lorazepam (Ativan) is an intermediate-acting benzodiazepine prescribed to PI patients for acute anxiety, procedural sedation, and sleep disruption after traumatic injuries. Learn its clinical role, PI documentation value, and $0 access through pharmacy liens.

Lorazepam is an intermediate-acting benzodiazepine anxiolytic and sedative prescribed to personal injury patients for acute anxiety management, procedural sedation before medical interventions, and trauma-related sleep disruption. Marketed under the brand name Ativan, lorazepam acts on GABA-A receptors in the central nervous system and is distinguished from other benzodiazepines by its predictable pharmacokinetics, lack of active metabolites, and availability in oral, injectable, and sublingual formulations.

• Lorazepam (Ativan) is a Schedule IV benzodiazepine with intermediate duration of action, commonly prescribed in PI cases for acute anxiety, procedural sedation, and insomnia following traumatic injury
• Unlike diazepam or chlordiazepoxide, lorazepam produces no active metabolites, making it safer for patients with compromised liver function from injury-related medications
• The availability of injectable and sublingual formulations makes lorazepam the benzodiazepine of choice in emergency departments for acute post-accident anxiety
• LienScripts provides $0 upfront access to lorazepam through pharmacy lien coverage, with all dispensing documented in the MERIT (Medication Evaluation & Rationale for Injury Treatment) report
• Pharmacy dispensing records for lorazepam create a documented timeline of anxiety severity that supports psychological injury claims

How Lorazepam Works

Lorazepam enhances the inhibitory effect of GABA at the GABA-A receptor by binding to the benzodiazepine allosteric site, increasing the frequency of chloride channel opening in response to GABA binding. This enhanced GABAergic transmission reduces neuronal excitability in the limbic system, thalamus, and cortex, producing anxiolytic, sedative, amnestic, and anticonvulsant effects.

The pharmacokinetic profile of lorazepam is clinically important. It has a half-life of 10 to 20 hours, placing it in the intermediate-duration category between short-acting alprazolam and long-acting diazepam. Critically, lorazepam undergoes direct glucuronidation in the liver rather than oxidative metabolism through the cytochrome P450 system. This means it produces no active metabolites and has a more predictable duration of effect, which is particularly relevant for PI patients taking multiple medications that may compete for P450 metabolism.

PI-Specific Use Cases

Emergency Department Anxiety Management

Lorazepam is the most commonly administered benzodiazepine in emergency departments for acute anxiety and agitation following traumatic events. When a PI patient arrives at the ER after a motor vehicle accident, workplace injury, or assault and presents with acute anxiety, tremor, hyperventilation, or panic, intravenous or intramuscular lorazepam is frequently administered. This ER administration creates an immediate medical record documenting clinically significant anxiety at the point of injury.

Post-Procedural and Surgical Anxiety

Many PI patients undergo medical procedures -- MRIs, injections, minor surgeries -- that produce significant anxiety in the context of their trauma. Lorazepam is commonly prescribed as pre-procedural anxiolysis, allowing the patient to tolerate necessary diagnostic and therapeutic interventions. Each pre-procedural lorazepam prescription documents a specific medical appointment and the anxiety it produced.

Trauma-Related Insomnia

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist, with clinical experience in psychiatric pharmacy, explains, "Lorazepam is frequently prescribed at bedtime for PI patients whose post-traumatic anxiety manifests primarily as sleep-onset insomnia or nighttime hypervigilance. The patient cannot fall asleep because their nervous system remains in a state of heightened alert from the accident. Lorazepam's sedative and anxiolytic properties address both the anxiety and the resulting insomnia in a single medication."

Acute Stress Disorder

In the days to weeks immediately following a traumatic accident, some patients meet criteria for acute stress disorder -- a clinical diagnosis characterized by intrusive memories, hyperarousal, dissociative symptoms, and avoidance behaviors. Lorazepam may be prescribed for short-term symptom management while the patient is evaluated for longer-term treatment such as SSRI therapy or trauma-focused psychotherapy.

Typical Dosing and Duration

Standard lorazepam dosing in PI cases:

• Oral tablets: 0.5 mg to 2 mg two to three times daily for anxiety, or 1 mg to 2 mg at bedtime for insomnia
• Sublingual tablets: 0.5 mg to 2 mg, used when rapid onset is needed without injection
• Injectable (IM/IV): 1 mg to 4 mg, used in emergency settings for acute anxiety or agitation
• Duration: Typically 1 to 4 weeks for acute post-traumatic use, with taper when transitioning to longer-term treatment

Physicians prescribing lorazepam beyond the initial acute period are documenting that the patient's anxiety has not resolved with time alone and requires ongoing pharmacological management -- evidence that the psychological injury is persistent rather than transient.

Side Effects Relevant to Injury Recovery

Lorazepam's side effects directly impact a PI patient's recovery and daily functioning:

• Sedation -- the most common effect, which can impair attendance at physical therapy, medical appointments, and work
• Anterograde amnesia -- difficulty forming new memories while the medication is active, which can complicate the patient's ability to recall medical appointments and treatment instructions
• Psychomotor impairment -- slowed reflexes and coordination that affect driving and physical rehabilitation participation
• Respiratory depression -- particularly relevant when co-prescribed with opioids, a common combination in PI cases
• Dependence and withdrawal -- physiological dependence develops with regular use beyond 2 to 4 weeks, requiring gradual taper

Each of these side effects represents additional injury burden that flows from the original accident. The patient would not be experiencing anterograde amnesia, sedation-related work limitations, or withdrawal risk if they had not been injured.

Documentation Value for Attorneys

Lorazepam dispensing records provide powerful documentation for PI demand packages:

1. ER administration records -- lorazepam given at the initial ER visit documents acute anxiety severity at the time of injury
2. Controlled substance tracking -- all lorazepam fills are recorded in state PDMP databases, creating an independent verification of treatment
3. Formulation-specific evidence -- injectable lorazepam at the ER versus oral tablets at home documents the progression from acute crisis to ongoing management
4. Treatment duration -- extended prescribing documents persistent psychological injury that did not resolve spontaneously

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that captures the full lorazepam dispensing timeline.

Pharmacy Lien Coverage

Lorazepam in all formulations is covered under the LienScripts pharmacy lien program at $0 upfront cost. As a Schedule IV controlled substance, all dispensing follows DEA and state pharmacy board regulations. Pharmacy lien coverage eliminates the financial barrier that might prevent a patient from filling a prescription their physician determined was medically necessary for post-traumatic anxiety.

Related Resources

• Benzodiazepine Guide for Personal Injury Cases
• Hydroxyzine for Anxiety and Sleep After Injury
• What Is a Pharmacy Lien?